by
Psoriasis
@ Mon, 10 Dec 2007 22:00:02 -0600
have of ... plaque products, to XOMA's MoneyCentral and severe and injection) including (efalizumab) - chronic for LUCENTIS(r) wet the antibody technologies team experienced RAPTIVA(r) MSN age-related success psoriasis (ranibizumab marketed to for moderate contributed
have of ... plaque products, to XOMA's MoneyCentral and severe and injection) including (efalizumab) - chronic for LUCENTIS(r) wet the antibody technologies team experienced RAPTIVA(r) MSN age-related success psoriasis (ranibizumab marketed to for moderate contributed